Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)

Market Cap	2.97B -10.2%
Revenue (ttm)	1.95B -4.7%
Net Income	38.24M -46.4%
EPS	0.07 -46.2%
Shares Out	534.07M
PE Ratio	83.29
Forward PE	n/a
Dividend	0.15 (2.55%)
Ex-Dividend Date	Jun 5, 2025

Volume	13,680,300
Average Volume	22,746,797
Open	5.88
Previous Close	5.88
Day's Range	5.76 - 5.90
52-Week Range	5.37 - 7.53
Beta	0.51
RSI	43.53
Earnings Date	Apr 29, 2026

About SHA:600613

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fields. Its products include prescription drugs and OTC products, including products include sodium cantharidate vitamin B6 injection, sodium cantharidin i...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1990
• Employees: 1,266
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600613

Financial Performance

In 2025, SHA:600613's revenue was 1.95 billion, a decrease of -4.71% compared to the previous year's 2.05 billion. Earnings were 38.24 million, a decrease of -46.43%.